Le mode conseil est activé Arrêter

XBI - SPDR S&P Biotech ETF (USD) (US78464A8707)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Sélectionnez tout Réinitialiser tout
 
(%)
US78464A8707
XBI ISIN
Fonds négociés en bourse (FNB)
Type de fonds
SPDR State Street Global Advisors
Fournisseur
155,46 USD
valeur liquidative par action | 14/07/2026
31/01/2006
Date de lancement
4 fois par an
Paiement de dividendes
CEOILS
CFI
XBI
Ticker
Formed
Status
Equity
Objet d'investissement
Biotech
Secteur
USA
Géographie
S&P Biotechnology Select Industry Index
Benchmark
0.35 %
Ratio de coût total
10.618,17 mln USD
Actif total du fonds | 14/07/2026
10.618,17 mln USD
Volume des actits de classe "actions" | 14/07/2026
Non
UCITS
1 / 3 (11/09/2015)
Split

Rendement au 14/07/2026, NYSE Arca

  • YTD
    5,06 %
  • 1M
    -7,93 %
  • 3M
    1,65 %
  • 6M
    11,2 %
  • 1Y
    62,15 %
  • 3Y
    51,47 %
  • 5Y
    0,91 %
  • 10Y
    143,19 %
Au prix de la bourse, avec prise en compte des paiements

Dernières données pour
Ajouter à comparer
de
au
ADD-IN
Add-in Cbonds API
bond data api

Cotations (XBI)

Explorer la base de données la plus complète

1 000 000

obligations

100 000

actions

175 910

ETF & Funds

100 000

indices

Suivre votre portefeuille de la manière la plus efficace

  • Screener d'obligations
  • liste de surveillance
  • Excel ADD-IN
Obtenir l'accès

Dynamique des prix

Fund profile

The SPDR S&P Biotech ETF seeks to replicate as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the biotechnology sector

XBI profile

The SPDR S&P Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 31.01.2006 with unique ISIN - US78464A8707. Main exchange is NYSE Arca and ticker symbol is XBI. The total expense ratio is 0.35%. The SPDR S&P Biotech ETF (USD) pays dividends 4 time(s) per year.

Structure XBI au 14/07/2026

Exporter la structure dans Excel
Titre Valeur
APOGEE THERAPEUTICS INC 1,56%
MODERNA INC 1,41%
ERASCA INC 1,4%
KYMERA THERAPEUTICS INC 1,38%
VIKING THERAPEUTICS INC 1,31%
ORUKA THERAPEUTICS INC 1,31%
TWIST BIOSCIENCE CORP 1,31%
PRAXIS PRECISION MEDICINES I 1,31%
DIANTHUS THERAPEUTICS INC 1,27%
SPYRE THERAPEUTICS INC 1,27%
CG ONCOLOGY INC 1,26%
MIRUM PHARMACEUTICALS INC 1,24%
RHYTHM PHARMACEUTICALS INC 1,23%
REVOLUTION MEDICINES INC 1,23%
NATERA INC 1,21%
CELCUITY INC 1,21%
BRIDGEBIO PHARMA INC 1,2%
PROTAGONIST THERAPEUTICS INC 1,19%
VAXCYTE INC 1,19%
ROIVANT SCIENCES LTD 1,18%
COGENT BIOSCIENCES INC 1,18%
CYTOKINETICS INC 1,17%
TRAVERE THERAPEUTICS INC 1,17%
SCHOLAR ROCK HOLDING CORP 1,17%
RELAY THERAPEUTICS INC 1,16%
INSMED INC 1,15%
ULTRAGENYX PHARMACEUTICAL IN 1,13%
TG THERAPEUTICS INC 1,13%
ALKERMES PLC 1,13%
SELLAS LIFE SCIENCES GROUP I 1,12%
SUMMIT THERAPEUTICS INC 1,11%
VERA THERAPEUTICS INC 1,1%
MADRIGAL PHARMACEUTICALS INC 1,09%
VERTEX PHARMACEUTICALS INC 1,05%
REGENERON PHARMACEUTICALS 1,05%
INCYTE CORP 1,05%
KRYSTAL BIOTECH INC 1,04%
ABBVIE INC 1,04%
GILEAD SCIENCES INC 1,03%
NEUROCRINE BIOSCIENCES INC 1,03%
HALOZYME THERAPEUTICS INC 1,02%
PTC THERAPEUTICS INC 1,02%
EXELIXIS INC 1,02%
AMGEN INC 1,01%
BEAM THERAPEUTICS INC 1,01%
GRAIL INC 1,01%
BIOMARIN PHARMACEUTICAL INC 1%
CRISPR THERAPEUTICS AG 0,98%
ACADIA PHARMACEUTICALS INC 0,98%
ARROWHEAD PHARMACEUTICALS IN 0,98%
IMMUNOVANT INC 0,96%
UNIQURE NV 0,96%
DYNE THERAPEUTICS INC 0,95%
IMMUNITYBIO INC 0,95%
NUVALENT INC A 0,95%
BIOGEN INC 0,95%
UNITED THERAPEUTICS CORP 0,93%
ALNYLAM PHARMACEUTICALS INC 0,93%
BIOCRYST PHARMACEUTICALS INC 0,9%
TANGO THERAPEUTICS INC 0,83%
SYNDAX PHARMACEUTICALS INC 0,82%
IDEAYA BIOSCIENCES INC 0,82%
VERACYTE INC 0,82%
SAREPTA THERAPEUTICS INC 0,77%
AGIOS PHARMACEUTICALS INC 0,77%
DENALI THERAPEUTICS INC 0,76%
ARCUTIS BIOTHERAPEUTICS INC 0,75%
CELLDEX THERAPEUTICS INC 0,75%
MINERALYS THERAPEUTICS INC 0,74%
INTELLIA THERAPEUTICS INC 0,74%
VIRIDIAN THERAPEUTICS INC 0,72%
IONIS PHARMACEUTICALS INC 0,72%
RECURSION PHARMACEUTICALS A 0,71%
ARCUS BIOSCIENCES INC 0,71%
DISC MEDICINE INC 0,69%
ADMA BIOLOGICS INC 0,67%
IMMUNOME INC 0,65%
KODIAK SCIENCES INC 0,63%
NOVAVAX INC 0,61%
PALVELLA THERAPEUTICS INC 0,59%
IOVANCE BIOTHERAPEUTICS INC 0,55%
BIOHAVEN LTD 0,55%
NURIX THERAPEUTICS INC 0,55%
VERICEL CORP 0,53%
ABSCI CORP 0,51%
MONTE ROSA THERAPEUTICS INC 0,48%
ANAPTYSBIO INC 0,48%
VIR BIOTECHNOLOGY INC 0,45%
HYPERLIQUID STRATEGIES 0,45%
STOKE THERAPEUTICS INC 0,44%
TYRA BIOSCIENCES INC 0,44%
CAPRICOR THERAPEUTICS INC 0,43%
CORVUS PHARMACEUTICALS INC 0,42%
CULLINAN THERAPEUTICS INC 0,41%
ZENAS BIOPHARMA INC 0,38%
ARDELYX INC 0,37%
INHIBRX BIOSCIENCES INC 0,36%
AVALO THERAPEUTICS INC 0,36%
PRECIGEN INC 0,35%
ANNEXON INC 0,33%
Montrer tout Cacher
Autres - %

Autres ETF et fonds de ce fournisseur

ETF et fonds similaires

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    Valeur nette d'actifs
    {{ item.expense_ratio }}
    Ratio de coût total
Vous devez vous inscrire pour y accéder.